The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isNone.
- What to watchRash, itching or swelling after the first uses.
How Cerebramin works
There is exactly one brain preparation in this whole catalog whose pharmacology somebody actually measured, and it is not this one. Kurkin 2021 took Cortexin — the injectable bovine cortex polypeptide complex — labeled it radioactively, and found it in mouse brain at 6 to 8% of the whole-blood concentration.
The same paper screened it against a receptor panel, and the answer was not the one the marketing predicts. High binding at AMPA (80.1%) and kainate (73.5%) receptors, moderate at mGluR1 (49.0%), GABA-A1 (44.0%) and mGluR5 (39.7%) Kurkin 2021. That is a glutamatergic profile.
The class claim is tissue-specific regulation of gene expression in the organ the extract came from. The only member of this family whose pharmacology has actually been measured is the injectable brain preparation Cortexin, which reached mouse brain at 6-8% of whole-blood concentration and screened as a glutamatergic agent — 80.1% binding at AMPA and 73.5% at kainate receptors — rather than as the DNA-binding regulator the class is sold as.
- Oral
On the goal map: Brain & pineal (Organ-specific bioregulation)
Research on Cerebramin5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: No published study of this product. The literature belongs to the parenteral extracts and the synthetic peptides of the same school.
Human clinical evidence
None. A PubMed search through PubTator3 for this product's name, run 8 September 2026, returned zero records. No trial, no case series, no pharmacokinetic study.
No completed human trial
Correlative data
The measured pharmacology in this family belongs to Cortexin, the injectable brain polypeptide: radiolabeled, it reached mouse brain at 6-8% of whole-blood concentration, and a receptor screen found 80.1% binding at AMPA and 73.5% at kainate receptors (Kurkin 2021). Different product, parenteral route.
Cortexin at 2-40 micrograms/ml protected cultured rat sensory neurons against 50 mM glucose, restoring a cell-index area-under-curve from 0.18 to 0.66 (Yazar 2023). Cells in a dish, material applied directly.
How the mechanism reads
The class claim is tissue-specific regulation of gene expression by short peptides released from an organ fraction. The receptor panel above points a different way — at fast excitatory transmission — and it is the manufacturer's own network that produced it.
MechanisticTwo barriers in series. A brain product has to survive digestion, cross the gut, and then cross a blood-brain barrier that the injectable work already found lets through under a tenth of what is in blood. Neither step has been measured for a tablet.
Mechanistic
Sources
- Khavinson VKh, Cherniak SI, D'iakonov MM. [Cytamines--preparations for maintaining high professional ability and longevity in servicemen]. Voenno-Meditsinskii Zhurnal 2001 [Russian] · PMID 11338817
- Emirova LR, Rozhkova EA, Paniushkin VV, Mirzoian RS, Seifulla NR. [The effects of cytamines and their combinations with ecdystene, apilak, vitamax, and essentiale on the work capability of athletes]. Eksperimental'naia i Klinicheskaia Farmakologiia 2004 [Russian] · PMID 15341074
- Ryzhak GA, Nekrasov PA, Kiselev OI, Khavinson VKh. Study of protein components of natural peptide regulators. Bulletin of Experimental Biology and Medicine 2003 · PMID 12717513
- Rozhkova EA, Ordzhonikidze ZG, Druzhinin AE, Seifulla NR, Paniushkin VV, Kuznetsov IuM. [Using carnosine and natural antioxidants for the prophylaxis of acute post-loading oxidative stress]. Eksperimental'naia i Klinicheskaia Farmakologiia 2007 [Russian] · PMID 18074807
- Kurkin DV. Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats. PLoS One 2021 · PMID 34260655
- Yazar U. Cortexin Ameliorates High Glucose-Induced Neuropathy in Cultured Rat Sensory Neurons. Neuroendocrinology 2023 · PMID 37080184
- Kurkin DV. Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay. Biomedicines 2025 · PMID 40299434
- Khavinson VKh, Malinin VV, Chalisova NI, Grigor'ev EI. [Tissue-specific action of peptides in tissue culture of rats of various ages]. Advances in Gerontology 2002;9:95-100 [Russian] · PMID 12096446
- Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN. [Polypeptides influence on tissue cell cultures regeneration of various age rats]. Advances in Gerontology 2015;28(1):97-103 [Russian] · PMID 26390619
- Tokaev ES. [Bioactive substance used for treatment and preventive maintenance of liver diseases]. Voprosy Pitaniia 2007 [Russian] · PMID 17802767
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
Cerebramin safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Allergy to animal proteins, since this is a crude brain-tissue extract.
- Unexplained memory decline, confusion or new headaches that have not been worked up.
- Autoimmune neurological disease, because animal-brain protein fragments are antigenic.
- Pregnancy or breastfeeding, where an uncharacterized animal extract has no record.
What’s expected
- Nothing established: no published study of this exact tablet exists.
- Any claimed effect is slow, tied to tissue-specific gene expression.
- Mild stomach upset is the plausible oral effect.
Watch for
- Rash, itching or swelling after the first uses.
- Headache with confusion or vision change.
- Memory complaints that worsen despite use.
Labs that tell you it’s working
- Complete Blood Count: eosinophils reveal an allergic response to animal-derived protein.
- Comprehensive Metabolic Panel: baseline liver and kidney function for an extract with no toxicology.
Oral polypeptide fraction from animal brain (the older Cytamin line) in the Khavinson tradition; no published adverse-event record exists. PMID 11338817 PMID 15341074
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Cerebramin FAQ4 common questions
- Is Cerebramin approved for human use?
- No. Cerebramin is a research compound. No completed randomized human trial has given it yet.
- What is Cerebramin researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- Complete Blood Count; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Cerebramin: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



